• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

控制私营部门的药品成本——以一项医疗福利计划为例。

Containing medicines costs in the private sector--the example of a medical benefit scheme.

作者信息

Hukins G, Boyce D

机构信息

Department of Family Health, University of the Witwatersrand, Johannesburg.

出版信息

S Afr Med J. 1990 Aug 4;78(3):152-4.

PMID:2116045
Abstract

Despite a pre-existing cost-containment programme, expenditure on medicines was identified as a source of further cost savings in a medical benefit scheme faced with increasing divergence between income and benefit expenditure. Analysis of medicines utilisation trends showed that a relatively small number of pharmaceutical products accounted for a high percentage of total medicines expenditure, and that a small number of pharmacies were dispensing a very high proportion of prescriptions. On the basis of these findings, a revised cost-containment programme for medicines was implemented. It consisted of a recommended medicines list, designed to rationalise selection and utilisation of medicines, and a 'preferred provider pharmacy' network that allowed further savings to be achieved. In its first 12 months, the programme allowed for savings of R305,000, or 37% of anticipated expenditure on medicines for that year. This represents a decrease over 1988 expenditure notwithstanding an increase in membership and medicine prices over the same period. There are therefore significant savings to be obtained by medical schemes through implementation of cost-containment programmes for medicines.

摘要

尽管已有一项成本控制计划,但在一个收入与福利支出差距日益扩大的医疗福利计划中,药品支出仍被视为进一步节省成本的来源。对药品使用趋势的分析表明,相对少数的药品占药品总支出的比例很高,而且少数药店配发了很高比例的处方。基于这些发现,实施了一项修订后的药品成本控制计划。该计划包括一份推荐药品清单,旨在使药品的选择和使用合理化,以及一个“首选供应商药店”网络,从而实现进一步的成本节约。在该计划实施的头12个月里,节省了30.5万兰特,占该年度预期药品支出的37%。尽管同期会员人数增加且药品价格上涨,但这仍比1988年的支出有所减少。因此,医疗计划通过实施药品成本控制计划可实现显著的成本节约。

相似文献

1
Containing medicines costs in the private sector--the example of a medical benefit scheme.控制私营部门的药品成本——以一项医疗福利计划为例。
S Afr Med J. 1990 Aug 4;78(3):152-4.
2
The maximum medical aid price programme. A review of the concept and of its ability to reduce expenditure on medicines.最高医疗救助价格计划。对该概念及其降低药品支出能力的综述。
S Afr Med J. 1990 Aug 4;78(3):147-51.
3
Strategies for managing prescription drug costs.管理处方药成本的策略。
Bus Health. 1990 Jun;8(6):41-2, 44.
4
Controlling prescription drug expenditures: a report of success.控制处方药支出:一份成功报告。
Am J Manag Care. 2007 Aug;13(8):473-80.
5
Drug purchasing: an evolutionary blueprint.药品采购:一份进化蓝图。
Bus Health. 1984 Mar;1(4):32-4.
6
Managing prescription drug costs: a case study.管理处方药成本:一个案例研究。
Med Interface. 1994 Jun;7(6):65-8, 70, 74.
7
Cost containment interventions introduced on the community drugs schemes in Ireland-evaluation of expenditure trends using a national prescription claims database.爱尔兰社区毒品计划中引入的成本控制干预措施——使用国家处方报销数据库评估支出趋势。
Clin Ther. 2012 Mar;34(3):632-9. doi: 10.1016/j.clinthera.2012.01.025. Epub 2012 Mar 3.
8
Spending on medicines in Israel in an international context.以色列药品支出的国际背景。
Isr Med Assoc J. 2005 May;7(5):286-91.
9
Reasons why insured consumers co-pay for medicines at retail pharmacies in Pretoria, South Africa.南非比勒陀利亚的参保消费者在零售药店为药品支付自付费用的原因。
Afr J Prim Health Care Fam Med. 2019 Mar 27;11(1):e1-e6. doi: 10.4102/phcfm.v11i1.1878.
10
How to restrain ballooning drug benefit costs.如何抑制不断膨胀的药品福利成本。
Bus Health. 1989 Apr;7(4):38-41, 43-6.

引用本文的文献

1
The state of health economic research in South Africa: a systematic review.南非健康经济研究状况:系统评价。
Pharmacoeconomics. 2012 Oct 1;30(10):925-40. doi: 10.2165/11589450-000000000-00000.
2
A review of limited lists and formularies: are they cost-effective?有限清单和处方集的综述:它们具有成本效益吗?
Pharmacoeconomics. 1992 Mar;1(3):191-202. doi: 10.2165/00019053-199201030-00006.